Rebalix
Logo InvescoInvesco · sheet of 4 September 2026
ETF sheet · official issuer and register data

Invesco EUR IG Corporate Bond Yield Plus UCITS ETF Acc

EYLA · IE0005F2R613 · class Acc · EUR · domicile Ireland
Bonds · Corporate EUR · Broad (all maturities) · GlobalSFDR art. 6
Index tracked: iBoxx EUR Corporates Investment Grade Spread Select Top 50% TCA Index TRI
TER
0.15%+ trans. 0.06%
Fund size
24 m EUR
Tracking difference
not computable
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Duration
4.55 yrsmedium (3–7 years)
Launch 25 Feb 2026 · costs from the KID as of 14 Aug 2026 · 245 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 14 Aug 2026
Investment objective: The objective of the Fund is to provide exposure to the performance of EUR denominated investment grade rated corporate bonds with a high Benchmark Spread. Dividend Policy: This Share Class does not pay you income, but instead reinvests it to grow your capital, in line with its stated objectives. Investment approach: The Fund is a passively managed ETF. To achieve the investment objective the Fund will seek to track the total return performance of the iBoxx EUR Corporates Investment Grade Spread Select Top 50% TCA Index (the…

Performance since series start (in euro) — base 100

25 Feb 20263 Sept 2026 · dividends reinvested where declared by the issuer
1009799
High 100 (26 Jun 2026) · low 97 (27 Mar 2026) · last 99. Past performance is not indicative of future results.

Returns in euro

1 yearseries too young
3 yearsseries too young
5 yearsseries too young
10 yearsseries too young
Since series start−1.3%

Risk · 1 / 3 / 5 years

Volatility (ann.)
Max drawdown
Sharpe
Sortino
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · EYLA · IE0005F2R6131
RebalixEYLA · IE0005F2R613 · sheet of 4 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years
Not honestly computable: index series not published by the issuer

Fixed income — as declared by the issuer

Factsheet · 31 Jul 2026 · investment-grade share (BBB−/Baa3 and above): 99.5%
Rating breakdown (% of fund)
AA1.5%A31.9%BBB66.1%Cash and derivatives0.5%
Maturity breakdown (% of fund)
9 to 12 months0.4%1 to 3 years17.2%3 to 5 years25.1%5 to 10 years36.9%10 to 20 years10.1%20+ years9.9%Cash and derivatives0.5%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 245 securities · top-10 weight = 5.9%
Countries (% of fund)
France18.9%United States18.6%Other16.4%Germany14.2%United Kingdom9.4%

Listing venues

ESMA register (FIRDS) and official exchange lists
EYLA · Borsa Italiana (ETFplus), Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 5 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Factsheet · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/shar
Prospectus · www.invesco.com/content/dam/invesco/emea/en/product-documents/etf/umbr
The live sheet, always up to date
rebalix.com/en/etf/IE0005F2R613
Series, distributions, holdings and documents refresh daily.
Sheet produced on 4 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · EYLA · IE0005F2R6132